Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Loans and Notes Receivables: 2019-2020

  • Genmab A's Loans and Notes Receivables rose 280.34% to $16.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $16.6 million, marking a year-over-year increase of 280.34%. This contributed to the annual value of $16.6 million for FY2020, which is 280.34% up from last year.
  • Per Genmab A's latest filing, its Loans and Notes Receivables stood at $16.6 million for Q4 2020, which was up 280.34% from $4.4 million recorded in Q4 2019.
  • Over the past 5 years, Genmab A's Loans and Notes Receivables peaked at $16.6 million during Q4 2020, and registered a low of $4.4 million during Q4 2019.
  • For the 2-year period, Genmab A's Loans and Notes Receivables averaged around $10.5 million, with its median value being $10.5 million (2019).
  • Data for Genmab A's Loans and Notes Receivables shows a peak YoY surged of 280.34% (in 2020) over the last 5 years.
  • Over the past 2 years, Genmab A's Loans and Notes Receivables (Quarterly) stood at $4.4 million in 2019, then spiked by 280.34% to $16.6 million in 2020.